SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-17-000049
Filing Date
2017-04-14
Accepted
2017-04-14 09:24:22
Documents
11
Period of Report
2017-04-14
Effectiveness Date
2017-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A lgnd-2017annualmeetingproxy.htm DEF 14A 905552
2 image0.jpg GRAPHIC 9775
3 image1a01.gif GRAPHIC 565
4 image2.gif GRAPHIC 1174
5 image3.gif GRAPHIC 612
6 image4.gif GRAPHIC 431
7 ligandpharmaceuticalsnot002.jpg GRAPHIC 172051
8 performancegrapha02.jpg GRAPHIC 267676
9 proxycard1032417v2001.jpg GRAPHIC 201184
10 proxycard032817001.jpg GRAPHIC 235727
11 proxycard2032417002.jpg GRAPHIC 105130
  Complete submission text file 0000886163-17-000049.txt   2263779
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 17762236
SIC: 2834 Pharmaceutical Preparations